JMC维卡格雷设计合成
Scheme1.MetabolicActivationofClopidogrelandProdrugScheme2.SynthesisofOpticallyActive2-Design
HydroxytetrahydrothienopyridineDerivatives9a va
theclinicalmanagementofCR.Novelantiplateletagentswithfastonsetofaction,lessinterindividualvariability,andlowriska
ofbleedingareurgentlyneeded.
GiventhefactthatclopidogrelisamongthemostwidelyCHReagentsand(R2CO)N,DMAPconditions:(cat.),(a)0°C;4-nitrobenzenesulfonyl(b)KHCOCN,chloride,2Cl2,Et33,CH3rt;(c)prescribeddrugsworldwideanditslong-termsafetyprofilehasNaH.For2O,CHR1and3CN,EtR2,see3N,0°Ctort,orR2COCl,THF,EtTable1.
3Norbeenestablishedafter14yearsofclinicaluse,newdrugdiscoverybasedonthisolddrugwouldbehighlydesirable.Asmethyl2-(2-chlorophenyl)-2-[(4-nitrobenzenesulfonyl)oxy]-NobellaureateJamesBlacksaid,“Themostfruitfulbasisfortheacetateandracemicmethyl2-(2-chlorophenyl)-2-[(4-discoveryofanewdrugistostartwithanolddrug.”Wenitrobenzenesulfonyl)oxy]acetate,respectively.Theopticalenvisionedthat,likethemetabolicpatternofprasugrel,esterpurity(%ee)ofcompounds9a vand(R)-9awasdetermined



prodrugs9mightbereadilyconvertedtoclopidogrelbychiralHPLC.
thiolactone(4a)byesterase-mediatedhydrolysisandsub-InhibitionofADP-InducedPlateletAggregationinsequentlytoclopidogrelAM(5)throughonlyoneCYP-RatsandSARAnalysis.Twenty-five2-hydroxytetrahydro-dependentstep(Scheme1).Inthisregard,9couldbeidealthienopyridinederivativeswereevaluatedfortheirinhibitorydrugcandidatesforovercomingCRwithoutincreasingtheriskeffectonADP-inducedplateletaggregationinratsatdoseof3ofbleedingandothersideeffectsassociatedwiththenewmg/kg.Clopidogrel(1)andprasugrel(2)wereusedaspositiveantiplateletagents.Herein,wereporttheidentificationofacontrols.ADP-inducedseriesof2-hydroxytetrahydrothienopyridinederivativesas8plateletaggregationwasdeterminedbyBorn’smethod.TheassayresultsaresummarizedinTable1.novelantiplateletagents.WealsodescribethedetailedInourpreliminarytests,althoughclopidogrelshowedstrongstructure activityrelationships(SARs)ofthisseriesofpotencyatadoseof10mg/kg(datanotshown),itwasalmostcompounds.Preliminaryefficacy,toxicity,andpharmacokineticinactiveatadoseof3mg/kg.Prasugrelwasthemostpotentstudiesledtothediscoveryofvicagrel(9a)asahighlypotentoneamongthissetoftestcompounds.Compound9aexhibitedand■
orallybioavailableantiplateletagent.
verystronginhibitoryeffectonplateletaggregationandwasonlyslightlylesspotentthanprasugrel.2-ChlorosubstitutionRESULTSANDDISCUSSION
seemedtobecriticalforthepotency(e.g.,9a c,l o),sinceChemistry.Opticallypure(R)-methyl2-(2-substitued-both2-hydrogenand2-fluorosubstitutionresultedinphenyl)-2-[(4-nitrobenzenesulfonyl)oxy]acetates7a cweresignificantlossofpotency(e.g.,9u,9v).2-Hydroxyesterpreparedviareactionofmandelicacidand2-substitutedmoietyofthetetrahydrothienopyridineringalsohadamandelicacidswith4-nitrobenzenesulfonylchlorideinthesignificantimpactonpotency.Interestingly,whenthesizeofpresenceoftriethylamineatlowtemperature(Scheme2).N-2-hydroxyalkylestersincreased,thepotencydecreasedAlkylationof5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-accordingly(e.g.,potencyintheorder9a>9b>9c>9d>onehydrochloride(8)with7a cinthepresenceofpotassium9e),suggestingthatthehindranceatthe2-estergroupsmightreducetheirhydrolysisratesandthusresultinlowerbicarbonateaffordedthiolactones4a c.Reactionof4a cwithconcentrationsofclopidogrelAM.Thesametendencywasacylanhydrides,acylchlorides,chlorocarbonicacidesters,orN-alsoobservedwithcarbonicacidesters(e.g.,potency,9m>9nsubstitutedcarbamicchloridesinthepresenceoftriethylamine>9p>9q).Itwasnotablethatthepotencyofcarbonicacidorsodiumhydridegaveopticallyactive2-hydroxytetrahydro-ester9mwassimilartothatofalkylester9a,indicatingthatthienopyridinederivatives9a vwith(S)-configuration.ThecarbonicacidesterscouldalsobeconvertedtoclopidogrelAMenantiomerof9a((R)-9a)andtheracemicmixtureof9aaswellasalkylesters.Notsurprisingly,clopidogrelthiolactone((R,S)-9a)werepreparedstartingfromopticallypure(S)-(4a)wasapotentantiplateletagent,albeitlesspotentthanits
热门文档